You are here

FDA Approves Epaned, Liquid Form of Enalapril, for Hypertension in Children and Adults

Product can be used in children as young as 1 month (August 14)

The FDA has approved Epaned (enalapril maleate powder for oral solution) to treat hypertension in children and adults aged 1 month and older. Enalapril — an angiotensin-converting enzyme (ACE) inhibitor — is one of the most commonly prescribed medicines in the U.S. to treat hypertension.

According to the product’s manufacturer (Silvergate Pharmaceuticals), Epaned allows accurate dosing for children who until now have relied on an adjusted adult dose. In addition, anyone who has difficulty swallowing enalapril tablets may respond well to the liquid formulation.

According to the International Pediatric Hypertension Association, the effects of hypertension can begin during childhood. Children with high blood pressure tend to have other medical problems, such as obesity, high blood lipids, and/or diabetes mellitus. In addition, children with hypertension tend to have the disorder as adults.

Source:; August 14, 2013.

Recent Headlines

Study finds fewer than half of trials followed the law
WHO to meet tomorrow to decide on international public heath emergency declaration
Study of posted prices finds wild variations and missing data
Potential contamination could lead to supply chain disruptions
Despite older, sicker patients, mortality rate fell by a third in 10 years
Declining lung cancer mortality helped fuel the progress
Kinase inhibitor targets tumors with a PDGFRA exon 18 mutation
Delayed surgery reduces benefits; premature surgery raises risks
Mortality nearly doubled when patients stopped using their drugs